Cargando…
Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice
Here, we aimed to investigate the potential role of DUSP6, a dual specificity phosphatase, that specifically inactivates extracellular signal-regulated kinase (ERK), for the regulation of body weight and glucose homeostasis. We further assessed whether metabolic challenges affect Dusp6 expression in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584967/ https://www.ncbi.nlm.nih.gov/pubmed/28873424 http://dx.doi.org/10.1371/journal.pone.0183488 |
_version_ | 1783261537340751872 |
---|---|
author | Pfuhlmann, Katrin Pfluger, Paul T. Schriever, Sonja C. Müller, Timo D. Tschöp, Matthias H. Stemmer, Kerstin |
author_facet | Pfuhlmann, Katrin Pfluger, Paul T. Schriever, Sonja C. Müller, Timo D. Tschöp, Matthias H. Stemmer, Kerstin |
author_sort | Pfuhlmann, Katrin |
collection | PubMed |
description | Here, we aimed to investigate the potential role of DUSP6, a dual specificity phosphatase, that specifically inactivates extracellular signal-regulated kinase (ERK), for the regulation of body weight and glucose homeostasis. We further assessed whether metabolic challenges affect Dusp6 expression in selected brain areas or white adipose tissue. Hypothalamic Dusp6 mRNA levels remained unchanged in chow-fed lean vs. high fat diet (HFD) fed obese C57Bl/6J mice, and in C57Bl/6J mice undergoing prolonged fasting or refeeding with fat free diet (FFD) or HFD. Similarly, Dusp6 expression levels were unchanged in selected brain regions of Lep(ob) mice treated with 1 mg/kg of leptin for 6 days, compared to pair-fed or saline-treated Lep(ob) controls. Dusp6 expression levels remained unaltered in vitro in primary adipocytes undergoing differentiation, but were increased in eWAT of HFD-fed obese C57Bl/6J mice, compared to chow-fed lean controls. Global chow-fed DUSP6 KO mice displayed reduced body weight and lean mass and slightly increased fat mass at a young age, which is indicative for early-age weight retardation. Subsequent exposure to HFD led to a significant increase in lean mass and body weight in DUSP6 deficient mice, compared to WT controls. Nevertheless, after 26 weeks of high-fat diet exposure, we observed comparable body weight, fat and lean mass in DUSP6 WT and KO mice, suggesting overall normal susceptibility to develop obesity. In line with the increased weight gain to compensate for early-age weight retardation, HFD-fed DUSP6 KO displayed increased expression levels of anabolic genes involved in lipid and cholesterol metabolism in the epididymal white adipose tissue (eWAT), compared to WT controls. Glucose tolerance was perturbed in both chow-fed lean or HFD-fed obese DUSP6 KO, compared to their respective WT controls. Overall, our data indicate that DUSP6 deficiency has limited impact on the regulation of energy metabolism, but impairs systemic glucose tolerance. Our data are in conflict to earlier reports that propose protection from diet-induced obesity and glucose intolerance in DUSP6 deficient mice. Reasons for the discrepancies remain elusive, but may entail differential genetic backgrounds, environmental factors such as the type and source of HFD, or alterations in the gut microbiome between facilities. |
format | Online Article Text |
id | pubmed-5584967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55849672017-09-15 Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice Pfuhlmann, Katrin Pfluger, Paul T. Schriever, Sonja C. Müller, Timo D. Tschöp, Matthias H. Stemmer, Kerstin PLoS One Research Article Here, we aimed to investigate the potential role of DUSP6, a dual specificity phosphatase, that specifically inactivates extracellular signal-regulated kinase (ERK), for the regulation of body weight and glucose homeostasis. We further assessed whether metabolic challenges affect Dusp6 expression in selected brain areas or white adipose tissue. Hypothalamic Dusp6 mRNA levels remained unchanged in chow-fed lean vs. high fat diet (HFD) fed obese C57Bl/6J mice, and in C57Bl/6J mice undergoing prolonged fasting or refeeding with fat free diet (FFD) or HFD. Similarly, Dusp6 expression levels were unchanged in selected brain regions of Lep(ob) mice treated with 1 mg/kg of leptin for 6 days, compared to pair-fed or saline-treated Lep(ob) controls. Dusp6 expression levels remained unaltered in vitro in primary adipocytes undergoing differentiation, but were increased in eWAT of HFD-fed obese C57Bl/6J mice, compared to chow-fed lean controls. Global chow-fed DUSP6 KO mice displayed reduced body weight and lean mass and slightly increased fat mass at a young age, which is indicative for early-age weight retardation. Subsequent exposure to HFD led to a significant increase in lean mass and body weight in DUSP6 deficient mice, compared to WT controls. Nevertheless, after 26 weeks of high-fat diet exposure, we observed comparable body weight, fat and lean mass in DUSP6 WT and KO mice, suggesting overall normal susceptibility to develop obesity. In line with the increased weight gain to compensate for early-age weight retardation, HFD-fed DUSP6 KO displayed increased expression levels of anabolic genes involved in lipid and cholesterol metabolism in the epididymal white adipose tissue (eWAT), compared to WT controls. Glucose tolerance was perturbed in both chow-fed lean or HFD-fed obese DUSP6 KO, compared to their respective WT controls. Overall, our data indicate that DUSP6 deficiency has limited impact on the regulation of energy metabolism, but impairs systemic glucose tolerance. Our data are in conflict to earlier reports that propose protection from diet-induced obesity and glucose intolerance in DUSP6 deficient mice. Reasons for the discrepancies remain elusive, but may entail differential genetic backgrounds, environmental factors such as the type and source of HFD, or alterations in the gut microbiome between facilities. Public Library of Science 2017-09-05 /pmc/articles/PMC5584967/ /pubmed/28873424 http://dx.doi.org/10.1371/journal.pone.0183488 Text en © 2017 Pfuhlmann et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Pfuhlmann, Katrin Pfluger, Paul T. Schriever, Sonja C. Müller, Timo D. Tschöp, Matthias H. Stemmer, Kerstin Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice |
title | Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice |
title_full | Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice |
title_fullStr | Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice |
title_full_unstemmed | Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice |
title_short | Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice |
title_sort | dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584967/ https://www.ncbi.nlm.nih.gov/pubmed/28873424 http://dx.doi.org/10.1371/journal.pone.0183488 |
work_keys_str_mv | AT pfuhlmannkatrin dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice AT pflugerpault dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice AT schrieversonjac dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice AT mullertimod dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice AT tschopmatthiash dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice AT stemmerkerstin dualspecificityphosphatase6deficiencyisassociatedwithimpairedsystemicglucosetoleranceandreversibleweightretardationinmice |